Sarcopenia

Decoding Sarcopenia: Advances in Research and Management: Dive into the evolving landscape of sarcopenia research. From cutting-edge studies on its impact on cancer patients to innovative management strategies, gain insights into combating this muscle-wasting condition.

Beyond Body Mass Index: The Impact of Height and Height-Normalised Weight on Overall Survival of Lung Cancer Undergoing Surgery.

Unlike most malignancies, increased adiposity, as expressed by a higher body mass index (BMI), is associated with improved prognosis after lung cancer surgery at the population level. Height, one of the determinants of BMI, is associated with better survival, independent...

๐Ÿ—“๏ธ 2025-08-01
๐Ÿ“ฐ Publication: Journal Of Cachexia Sarcopenia And Muscle
Read MoreBeyond Body Mass Index: The Impact of Height and Height-Normalised Weight on Overall Survival of Lung Cancer Undergoing Surgery.

Characterizing sarcopenia and sarcopenic obesity in patients aged 65 years and over, at risk of mobility disability: a multicenter observational trial (SARA-OBS).

Aging is associated with a progressive change of body composition characterized by muscle mass decline and accumulation of adipose tissue that can lead to sarcopenia and obesity, respectively. The prevalence of sarcopenia is poorly known given the different parameters and...

๐Ÿ—“๏ธ 2025-08-04
Read MoreCharacterizing sarcopenia and sarcopenic obesity in patients aged 65 years and over, at risk of mobility disability: a multicenter observational trial (SARA-OBS).

Genome-wide association and epidemiological evidence linking air pollution to aging mechanisms.

This study aimed to investigate the effects of air pollution on aging and aging-related diseases, focusing on potential causal relationships and molecular mechanisms. The first part involved a comprehensive analysis of global studies, examining the associations among PM 2.5 exposure,...

๐Ÿ—“๏ธ 2025-07-16
๐Ÿ“ฐ Publication: Journal Of Hazardous Materials
Read MoreGenome-wide association and epidemiological evidence linking air pollution to aging mechanisms.

Bioelectrical impedance analysis for sarcopenia: a systematic review and meta-analysis of diagnostic accuracy.

To evaluate the diagnostic performance of bioelectrical impedance analysis (BIA) for detecting sarcopenia across diverse populations. We conducted a search of MEDLINE, Embase, and Web of Science up to 2 January 2024. Cross-sectional, retrospective, and prospective cohort studies evaluating BIA's...

๐Ÿ—“๏ธ 2025-05-31
๐Ÿ“ฐ Publication: Age And Ageing
Read MoreBioelectrical impedance analysis for sarcopenia: a systematic review and meta-analysis of diagnostic accuracy.

The Interface of a Leaky Gut with Reduced Sarcopenia-Related Quality of Life (SarQoL) in Patients with Chronic Obstructive Pulmonary Disease.

Patients with chronic obstructive pulmonary disease (COPD) frequently exhibit intestinal leaks and age-related muscle impairment, termed sarcopenia. The sarcopenia-related quality-of-life (SarQoL) is a tool to evaluate the quality of life of sarcopenic patients. However, the association of intestinal leak with...

๐Ÿ—“๏ธ 2025-06-24
๐Ÿ“ฐ Publication: International Journal Of Chronic Obstructive Pulmonary Disease
Read MoreThe Interface of a Leaky Gut with Reduced Sarcopenia-Related Quality of Life (SarQoL) in Patients with Chronic Obstructive Pulmonary Disease.

Consolidating Concepts from Recent International Expert Consensus on Sarcopenia: Implications for Heart Failure Management.

Heart failure is a clinical syndrome associated with a range of pathophysiological disorders including secondary sarcopenia that reduces patients' quality of life, mobility, physical fitness and capacity to undergo rehabilitation and recovery from acute decompensation. Although international expert writing groups...

๐Ÿ—“๏ธ 2025-06-16
๐Ÿ“ฐ Publication: Journal Of Cardiac Failure
Read MoreConsolidating Concepts from Recent International Expert Consensus on Sarcopenia: Implications for Heart Failure Management.

Volatile organic compounds exposure, biological ageing, and increased sarcopenia risk: Association, interaction, and mechanistic exploration.

Evidence on the impacts of volatile organic compounds (VOCs), a class of ubiquitous environmental toxics, on sarcopenia, a major age-related global health issue, remains scarce. Data from 3007 adults in the National Health and Nutrition Examination Survey (2011-2018) were analyzed...

๐Ÿ—“๏ธ 2025-06-13
๐Ÿ“ฐ Publication: Journal Of Hazardous Materials
Read MoreVolatile organic compounds exposure, biological ageing, and increased sarcopenia risk: Association, interaction, and mechanistic exploration.

The impact of sarcopenia on sarcoma patients: a systematic review and meta-analysis.

Sarcopenia has been linked to poor outcomes in various cancers, but its specific effect on sarcoma patients remains unclear. This systematic review and meta-analysis investigates the impact of sarcopenia, estimated using CT, on sarcoma patients, focusing on prognostic implications and...

๐Ÿ—“๏ธ 2025-06-03
๐Ÿ“ฐ Publication: Radiologia Medica
Read MoreThe impact of sarcopenia on sarcoma patients: a systematic review and meta-analysis.

The predictive and prognostic role of radiologically defined sarcopenia in head and neck cancer: a systematic review and multi-level meta-analysis.

Radiologically defined sarcopenia (RS), defined as a lack of skeletal muscle mass (SMM) measured on cross-sectional CT or MR imaging, is increasingly recognized as a significant prognostic determinant in head and neck cancer (HNC). A systematic literature search of Embase...

๐Ÿ—“๏ธ 2025-06-02
๐Ÿ“ฐ Publication: British Journal Of Cancer
Read MoreThe predictive and prognostic role of radiologically defined sarcopenia in head and neck cancer: a systematic review and multi-level meta-analysis.

Association of the Dietary Index for Gut Microbiota With Severity, Renal Function, and Sarcopenia in Patients With Chronic Kidney Disease: A Population-Based Cross-Sectional Study.

The aim of this research was to clarify the relationship between the Dietary Index for Gut Microbiota (DI-GM) and the severity of chronic kidney disease (CKD), renal function, and the prevalence of sarcopenia in patients with CKD, as well as...

๐Ÿ—“๏ธ 2025-05-18
Read MoreAssociation of the Dietary Index for Gut Microbiota With Severity, Renal Function, and Sarcopenia in Patients With Chronic Kidney Disease: A Population-Based Cross-Sectional Study.

Association between cumulative pack-year smoking exposure and sarcopenia: a KoGES cohort study.

Sarcopenia is the age-related involuntary loss of skeletal muscle mass and strength. Many factors, such as ageing and behaviour, may affect the risk of sarcopenia. However, no study had confirmed the association between cumulative exposure to smoking and the risk...

๐Ÿ—“๏ธ 2025-04-12
๐Ÿ“ฐ Publication: International Journal Of Epidemiology
Read MoreAssociation between cumulative pack-year smoking exposure and sarcopenia: a KoGES cohort study.

Sarcopenia in heart failure: Comparison of prognostic value between the Asian working Group for Sarcopenia 2014 and 2019 criteria.

Sarcopenia is a prevalent comorbidity among older patients with heart failure. This study aimed to evaluate the differences between sarcopenia diagnosed using the Asian Working Group for Sarcopenia (AWGS) 2014 and 2019 criteria in older patients with heart failure. This...

๐Ÿ—“๏ธ 2025-05-06
๐Ÿ“ฐ Publication: Geriatrics & Gerontology International
Read MoreSarcopenia in heart failure: Comparison of prognostic value between the Asian working Group for Sarcopenia 2014 and 2019 criteria.

SARCOPENIA DEFINITION

Sarcopenia is a condition which focuses on muscle loss. Loss of muscle mass and function, especially muscle strength and gait speed, associated with aging occurs in sarcopenia. Sarcopenia, cachexia, and malnutrition are considered as the main causes of muscle wasting and affect millions of elderly people and patients. Moreover, muscle atrophy can develop independently from diseases and age through disuse of the muscles. For a better classification and common language in medical science for โ€˜muscle wasting diseaseโ€™ there is a proposal to combine the concepts of muscle wasting, sarcopenia, frailty, and cachexia by disease aetiology and disease progression. Patients with muscle atrophy show decreased muscle strength and therefore reduced quality of life, which is caused by a lower activity and increased exercise intolerance.

Despite a large number of studies, the understanding of the development of muscle wasting and the involved pathways remains very limited and more research is needed. Although many researchers and pharmaceutical companies have tried to find therapies for muscle atrophy, including cachexia and sarcopenia, no solution has been established until now.

REFERENCES

Rosenberg IH. Sarcopenia: origins and clinical relevance. Clin Geriatr Med 2011;27:337โ€“339.

Anker SD, Coats AJ, Morley JE, Rosano G, Bernabei R, von Haehling S, Kalantar-Zadeh K. Muscle wasting disease: a proposal for a new disease classification. J Cachexia Sarcopenia Muscle 2014;5:1โ€“3

Subscribe to the SCWD Newsletter

Stay Informed with the Latest Updates and Exclusive Insights!